Evaluation of the Potential Prognostic Value of Tumor Budding in Laryngeal Carcinoma by Conventional and Immunohistochemical Staining

Figure 5

(a) Local recurrence disease-free survival in no/mild (low intensity) budding and moderate/marked (high intensity) budding evaluated by H&E; (b) local recurrence disease-free survival in no/mild (low intensity) budding and moderate/marked (high intensity) budding evaluated by pancytokeratin IHC; (c) distant metastasis-free survival in no/mild (low intensity) budding and moderate/marked (high intensity) budding evaluated by H&E; (d) distant metastasis-free survival in no/mild (low intensity) budding and moderate/marked (high intensity) budding evaluated by pancytokeratin IHC.

(a)

(b)

(c)

(d)